Literature DB >> 9686792

Ventricular arrhythmia following successful myocardial revascularization: incidence, predictors and prevention.

T K Kaul1, B L Fields, L S Riggins, D A Wyatt, C R Jones.   

Abstract

OBJECTIVES: We estimated the risk of sudden cardiac death (SCD), from a spontaneous episode of ventricular arrhythmia (VT/VF), after a successful surgical myocardial revascularization (coronary artery bypass grafting; CABG) procedure. Predictors of these events were identified, and long term benefits of the prophylactic regimes, that were used to control these events, were evaluated.
METHODS: We selected 8642 consecutive patients, who had undergone an isolated and first time CABG procedure, between 1/3/1980 and 1/3/1995. A standard hazard function model (1) was used for statistical analysis. Efficacy of the prophylactic regimes, was examined in a group of 350 high risk patients, with a preoperative left ventricular ejection fraction 30% or less, who were recently operated since 1/1/1988. Electrophysiologic (EP) guided prophylaxis was used in 92 (26%) patients, who had survived a documented episode of SCD, and remaining 258 patients were maintained on antiarrhythmic medication on an empirical basis. A sequential EP evaluation was performed, when indicated.
RESULTS: During an early phase of hazard, which mainly lasted for up to 3 months after CABG, incremental risk factors were preoperative LVEF 30% or less (P = 0.0007) and preoperative episodes of VT/VF (P = 0.04). This phase was followed by a constant phase with a low risk of the events, which merged into a slowly rising late phase after 6 years. EP guided prophylaxis, reduced the risk of SCD in high risk patients (P = 0.03). A sequential EP evaluation, helped to detect the problems of drug resistance and a cross over from non-sustained to sustained runs of VT/VF.
CONCLUSIONS: Despite a successful CABG surgery, risk of VT/VF persists. A routine EP evaluation before and after a CABG procedure is recommended in all patients with a poor left ventricular function.

Entities:  

Mesh:

Year:  1998        PMID: 9686792     DOI: 10.1016/s1010-7940(98)00085-2

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  Perioperative correlates of malignant ventricular tachyarrhythmias complicating coronary surgery.

Authors:  V Ducceschi; A D'Andrea; B Liccardo; B Sarubbi; L Ferrara; A Alfieri; G P Romano; L Santangelo; A Iacono; M Cotrufo
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Surgery for ventricular tachycardia in patients undergoing surgical ventricular restoration: the Karolinska approach.

Authors:  Ulrik Sartipy; Anders Albåge; Per Insulander; Dan Lindblom
Journal:  J Interv Card Electrophysiol       Date:  2007-09-09       Impact factor: 1.900

3.  The effect of myocardial surgical revascularization on left ventricular late potentials.

Authors:  L Can; M Kayikçioğlu; H Halil; H Kültürsay; H Evrengül; K Kumanlioğlu; C Türkoglu
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-04       Impact factor: 1.468

4.  Surgical Ventricular Restoration: An Operation to Reverse Remodeling - Clinical Application (Part II).

Authors:  Ganesh Shanmugam; Imtiaz S Ali
Journal:  Curr Cardiol Rev       Date:  2009-11

5.  Implantable cardioverter-defibrillators improve survival after coronary artery bypass grafting in patients with severely impaired left ventricular function.

Authors:  Ashraf S Al-Dadah; Rochus K Voeller; Paymon Rahgozar; Jennifer S Lawton; Marc R Moon; Michael K Pasque; Ralph J Damiano; Nader Moazami
Journal:  J Cardiothorac Surg       Date:  2007-01-12       Impact factor: 1.637

6.  Wearable cardioverter defibrillator multicentre experience in a large cardiac surgery cohort at transient risk of sudden cardiac death.

Authors:  Christian Kuehn; Stefan Ruemke; Philipp Rellecke; Artur Lichtenberg; Dominik Joskowiak; Christian Hagl; Mohamed Hassan; Rainer G Leyh; Stefan Erler; Jens Garbade; Sandra Eifert; Philippe Grieshaber; Andreas Boening; Torsten Doenst; Ilia Velichkov; Tomas Madej; Michael Knaut; Andreas Hain; Heiko Burger
Journal:  Eur J Cardiothorac Surg       Date:  2022-05-02       Impact factor: 4.534

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.